Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Seufferlein

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Zeitschrift Fur Gastroenterologie|October 26, 2006
[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006]A Reinacher-Schick, D Arnold, F Lordick, et al.
Pancreas|October 9, 2001
Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levelsV Stagge, T Seufferlein, D Duerschmied, et al.
Cancer Research|July 14, 1998
Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreasS Gansauge, F Gansauge, Y Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaG Folprecht, M P Lutz, P Schöffski, et al.
FEBS Letters|January 2, 1996
Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cellsD J Withers, H A Coppock, T Seufferlein, et al.
Zeitschrift Fur Gastroenterologie|May 13, 2016
[Obstacles and facilitators of conducting studies - the perspective of colorectal cancer centers' coordinators]C Kowalski, J Ferencz, S Benz, et al.
British Journal of Cancer|March 6, 2003
KOC is a novel molecular indicator of malignancyF Mueller, M Bommer, U Lacher, et al.
Pancreas|October 9, 2001
Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progressionB Poch, F Gansauge, A Schwarz, et al.
Zeitschrift Fur Gastroenterologie|May 23, 2013
[Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)]C Lübbert, C Johann, A S Kekulé, et al.
Cancer Research|May 19, 2001
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activationV Ellenrieder, S F Hendler, W Boeck, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Zeitschrift Fur Gastroenterologie|October 26, 2006
[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006]A Reinacher-Schick, D Arnold, F Lordick, et al.
Pancreas|October 9, 2001
Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levelsV Stagge, T Seufferlein, D Duerschmied, et al.
Cancer Research|July 14, 1998
Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreasS Gansauge, F Gansauge, Y Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaG Folprecht, M P Lutz, P Schöffski, et al.
FEBS Letters|January 2, 1996
Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cellsD J Withers, H A Coppock, T Seufferlein, et al.
Zeitschrift Fur Gastroenterologie|May 13, 2016
[Obstacles and facilitators of conducting studies - the perspective of colorectal cancer centers' coordinators]C Kowalski, J Ferencz, S Benz, et al.
British Journal of Cancer|March 6, 2003
KOC is a novel molecular indicator of malignancyF Mueller, M Bommer, U Lacher, et al.
Pancreas|October 9, 2001
Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progressionB Poch, F Gansauge, A Schwarz, et al.
Zeitschrift Fur Gastroenterologie|May 23, 2013
[Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)]C Lübbert, C Johann, A S Kekulé, et al.
Cancer Research|May 19, 2001
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activationV Ellenrieder, S F Hendler, W Boeck, et al.
Pageof 9